chr21-44294404-G-A

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PP3BP6_Very_StrongBS1BS2

The NM_000383.4(AIRE):​c.1404G>A​(p.Thr468Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00179 in 1,569,294 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T468T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0057 ( 11 hom., cov: 31)
Exomes 𝑓: 0.0014 ( 13 hom. )

Consequence

AIRE
NM_000383.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.66

Publications

1 publications found
Variant links:
Genes affected
AIRE (HGNC:360): (autoimmune regulator) This gene encodes a transcriptional regulator that forms nuclear bodies and interacts with the transcriptional coactivator CREB binding protein. The encoded protein plays an important role in immunity by regulating the expression of autoantigens and negative selection of autoreactive T-cells in the thymus. Mutations in this gene cause the rare autosomal-recessive systemic autoimmune disease termed autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy (APECED). [provided by RefSeq, Jun 2012]
AIRE Gene-Disease associations (from GenCC):
  • autoimmune polyendocrine syndrome type 1
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, PanelApp Australia, Ambry Genetics, Myriad Women’s Health, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • familial isolated hypoparathyroidism due to impaired PTH secretion
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BP6
Variant 21-44294404-G-A is Benign according to our data. Variant chr21-44294404-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 35661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00566 (857/151398) while in subpopulation AFR AF = 0.0165 (679/41190). AF 95% confidence interval is 0.0155. There are 11 homozygotes in GnomAd4. There are 405 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AIRENM_000383.4 linkc.1404G>A p.Thr468Thr synonymous_variant Exon 12 of 14 ENST00000291582.6 NP_000374.1 O43918-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AIREENST00000291582.6 linkc.1404G>A p.Thr468Thr synonymous_variant Exon 12 of 14 1 NM_000383.4 ENSP00000291582.5 O43918-1

Frequencies

GnomAD3 genomes
AF:
0.00566
AC:
857
AN:
151280
Hom.:
11
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0165
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00545
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000944
Gnomad OTH
AF:
0.00289
GnomAD2 exomes
AF:
0.00208
AC:
380
AN:
182778
AF XY:
0.00169
show subpopulations
Gnomad AFR exome
AF:
0.0147
Gnomad AMR exome
AF:
0.00212
Gnomad ASJ exome
AF:
0.00381
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000118
Gnomad NFE exome
AF:
0.000847
Gnomad OTH exome
AF:
0.00166
GnomAD4 exome
AF:
0.00138
AC:
1957
AN:
1417896
Hom.:
13
Cov.:
31
AF XY:
0.00133
AC XY:
937
AN XY:
703108
show subpopulations
African (AFR)
AF:
0.0185
AC:
610
AN:
32988
American (AMR)
AF:
0.00253
AC:
103
AN:
40746
Ashkenazi Jewish (ASJ)
AF:
0.00362
AC:
92
AN:
25430
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38368
South Asian (SAS)
AF:
0.00238
AC:
194
AN:
81588
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
36728
Middle Eastern (MID)
AF:
0.00860
AC:
47
AN:
5462
European-Non Finnish (NFE)
AF:
0.000682
AC:
749
AN:
1097516
Other (OTH)
AF:
0.00274
AC:
162
AN:
59070
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
85
169
254
338
423
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00566
AC:
857
AN:
151398
Hom.:
11
Cov.:
31
AF XY:
0.00547
AC XY:
405
AN XY:
74000
show subpopulations
African (AFR)
AF:
0.0165
AC:
679
AN:
41190
American (AMR)
AF:
0.00545
AC:
83
AN:
15240
Ashkenazi Jewish (ASJ)
AF:
0.00490
AC:
17
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5066
South Asian (SAS)
AF:
0.00105
AC:
5
AN:
4784
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10558
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000944
AC:
64
AN:
67800
Other (OTH)
AF:
0.00286
AC:
6
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
38
76
115
153
191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00207
Hom.:
1
Bravo
AF:
0.00682
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Polyglandular autoimmune syndrome, type 1 Benign:2
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 18, 2011
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing;curation

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AIRE: BS1, BS2 -

not specified Benign:1
Aug 17, 2020
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
16
DANN
Benign
0.64
PhyloP100
-1.7
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.59
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.59
Position offset: 2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7281600; hg19: chr21-45714287; API